CraigAMullenMD

Pediatric Hematology & Oncology • Rochester, NY

Professor of Pediatrics, University Rochester

Join to view full profile

Dr. Mullen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mullen's full profile

Already have an account?

Office
601 Elmwood Ave
Box 635
Rochester, NY 14642
Phone+1 585-275-7787

Education & Training

National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1989 - 1992
National Capital ConsortiumResidency, Pediatrics, 1989 - 1990
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1988 - 1989
University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1986 - 1987
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 2003 - 2025
TX State Medical License 1987 - 2004
MD State Medical License 1989 - 1995
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

585 Magazine Castle Connolly, 2012

Publications & Presentations

PubMed

406 citations
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system
Craig A. Mullen, M Kilstrup, R M Blaese
Proceedings of the National Academy of Sciences of the United States of America. 1992-01-01
375 citations
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
Alison G Freifeld, Eric J Bow, Kent A Sepkowitz, Michael J Boeckh, James I Ito
Clinical Infectious Diseases. 2011-02-15
914 citations
T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years
R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Charles S. Carter, Thomas A. Fleisher
Science. 1995-10-20

Grant Support

Predictive Mathematical Models For Rational Design Of Chemoimmunotherapy Of LeukeNational Cancer Institute2009–2010
Leukemia Immunotherapy After Allogeneic TransplantNational Cancer Institute2004–2008